Matthew Kaeberlein, Ph.D. and Daniel Promislow, Ph.D. Highlighted in New York Times Article

2015-promislow_daniel_web__profile
Daniel Promislow, Ph.D.
2015-kaeberlein_matt_web__profile
Matthew Kaeberlein, Ph.D.

The research contributions of Matthew Kaeberlein, Ph.D. and Daniel Promislow, Ph.D. on identifying genetic and environmental factors that modulate longevity were recently highlighted in a New York Times article.  Join us is congratulating Dr. Kaeberlein and Promislow for forwarding the national discussion on aging and its impact on human disease.  Read the NYT article titled “Dogs Test Drug Aimed at Humans’ Biggest Killer: Age” here.